Search

The article features eye care products company Alcon. In 2012, Alcon merged with CIBA Vision, creating what is known as the world's largest eye care company. The company will reportedly launch a 'breakthrough technology' in 2013 in contact lenses which comes with a full training programme at the Alcon Academy at Watchmoor Park. Known to offer a wide array of contact lenses and lens care, Alcon's other products include Air Optix, Dailies and FreshLook contact lenses.

Comments on the plans of Nestlé to bring public Alcon, its eye care company. Expected interest of investors in the company's stock; Profits for the company; How Nestlé's plans for profits from the sale of Alcon stocks could hurt Alcon's finances; Competition for Alcon from Allergan.

The article offers news briefs on the contact lens sector as of February 2010. The U.S. rights for the topical eyecare products Durezol and Zirgan from Sirion Therapeutics will be purchased by Alcon. The Crystalens AO aberration-free accommodating intraocular lens (IOL) with aspheric optics from Bausch + Lomb has been introduced internationally to cataract surgeons. The Phase 3 clinical trial of Prolacria 2% for dry eyes disease treatment did not meet Inspire Pharmaceuticals' primary and secondary endpoints.

The article offers news briefs related to contact lens industry in the U.S. The Contact Lens Manufacturers Association Seal of Excellence for 2009-2010 was received by ABB Concise. The AcrySof IQ Toric intraocular lens by Alcon Inc. was approved by U.S. Food and Drug Administration (FDA). The fourth annual "Eyes on Capitol Hall" event was conducted by Prevent Blindness America in Washington, D. C. from March 2-4, 2009.

The article reports on the introduction of Alcon's Pataday solution for the treatment of ocular allergies. According to Alcon, Pataday solution is the first and only once-daily topical ocular allergy product. The solution is composed of olopatadine concentration which has been doubled from the 0.1 percent in Patanol solution to the 0.2 percent. It asserts that the increase in concentration may improve the immediate efficacy of the drug not just its duration of action.

Presents several eye care related products from various companies. Specifications of the Infiniti Vision System from Alcon Inc.; Power capacity of the Sovereign Compact cataract removal machine from Advanced Medical Optics Inc.; Availability of the gatifloxacin drug from Allergan Inc.

Provides information on several eye medicines and other eye care products. Clens100 contact lens re-wetting solution from Alcon; Hypromellose eye drop from Tubilux; Opatanol eye drops from Alcon.

This article provides information on Systane Balance Lubricant Eye Drops from Alcon.

The article presents news briefs regarding the contact lens industry. The U.S. Federal Trade Commission has warned 15 sellers of non-corrective cosmetic contact lenses for providing them to consumers without valid prescriptions. A study has found that the use of loteprednol etabonate with topical cyclosporine ophthalmic emulsion provide faster relief of dry eye symptoms. Alcon has obtained FDA approval for its Triesence synthetic corticosteroid for visualization during vitrectomy.

The article reports the product recall on Alcon's Systane Free Liquid Gel lubricant eye drops. The recall is in response to 11 consumer reports citing the presence of foreign material. The company has distributed more than 50 million bottles since its introduction in January 2006. The bottles were examined which identifies the foreign material as mold, however, because of the characteristics of theses molds , the development of infection is considered unlikely.

Features various products for medical care in the U.S. Product offering of the Infiniti Vision System by Alcon Inc.; Distinct features of the Sovereign System with Whitestar technology from Advanced Medical Optics Inc.; Specification of Sonic Wave from Staar Surgical Co. INSET: Microincision Cataract Surgery -- One Step Closer.

The article features several contact lenses displayed at the 2012 British Contact Lens Association (BCLA) clinical conference and exhibitions, including the Dailies Total1 Water Gradient Silicone Hydrogel contact lenses from Alcon, Biotrue Oneday from Bausch + Lomb and C2 Silicone Hydrogel Multifocal from David Thomas Contact Lenses.

The article reports on the acquisition of the firm Alcon Inc. with Novartis AG. Under the terms of the merger, Alcon shareholders will receive 2.9228 Novartis shares It mentions that the firm Alcon Inc. is the leading eye care company, with sales of about 7.2 billion dollars in 2010. Under the acquisition terms, the shareholders of Alcon will receive 2.9228 Novartis shares or American Depositary Shares and a cash payment of 8.20 dollars for each Alcon share.

The article evaluates the DAILIES TOTAL1® water gradient contact lens from eye care provider Alcon.

The article features a variety of products relating to keeping eyes healthy, including the Ultra eyedrop from Alcon, the Ocuvite Complete supplement from Bausch & Lomb, and the Eye Care Cosmetics from Butterflies Healthcare.

The article offers information on the planning of Novartis AG (NVS) to buy Alcon Inc. (ACL) from Nestle SA (NSRGY). Daniel Vasella, Chief Executive Officer (COE) at Novartis told that they would spend 39.3 billion dollars on acquiring the minority shareholders of ACL. It informs that Novartis after buying ACL will expand its eye care businesses including Lucentis blindness medicine and Ciba Vision.

The article presents corporate efforts to change public attitudes for the better in 2017. Alcon Inc. pledged to offer $5 to Think About Your Eyes program for each annual supply of its contact lenses bought, to encourage healthy wear schedules and support the public advocacy goals of the campaign. The corporate efforts help people change their lifestyles in ways that promote wellness and health, a too-rare confluence of altruism and capitalism.

The article offers brief information on several eye care solutions including the Air Optix plus HydraGlyde contact lens from Alcon Inc., the multidose restasis bottle and the Xen glaucoma treatment system, both from Allergan PLC.

The article evaluates several optometry equipment including the App Visit diagnostic system from AppMedicine, the Alcon's Clear Care Solution from Alcon, and Transitions Signature VII lenses from Essilor.

In this article, author discusses the astigmatic contact lens options which includes several types, Air Optix for astigmatism (Alcon Inc.), Biofinity Toric (CooperVision Inc.) and Purevision 2 for astigmatism (Bausch & Lomb Inc.). It mentions that these have the capability to correct upto 2.25 D of astigmatism. It also discusses other toric lens options including daily disposable lenses, low toric option, single-vision contact lenses, and hybrid lens technology.

The article focuses on the acquisition of eye care company Alcon Inc. by Novartis AG. It states that Alcon's business will merge with Novartis to become the second-largest division in Novartis' profile. Further it mentions that Alcon will realign its business units into three separate divisions that include surgical business, pharmaceutical business, and vision-care business.

The article reports on the approval of the 12.9 billion U.S. dollars merger between Novartis AG and Alcon Inc. by Alcon's board of directors on December 15, 2010. It notes that the companies have agreed on merger terms that raise the offer to minority shareholders of Alcon by 15 U.S. dollars per share. Kevin Buehler, president of Novartis, says the merger will create a stronger eye-care business with broader commercial reach and enhanced capabilities to develop more innovative eye-care products.

This section offers news briefs related to eye care. Alcon's once-daily prescription eye drop Travatan Z has been approved for first-line treatment of elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension. Bausch + Lomb is offering a direct-to-the consumer rebate program for Crystalens to increase patient adoption. A successful Proof of Principle clinical study has been completed by Ocular Therapeutix with its sustained drug delivery moxifloxacin punctal plug.

This section offers news briefs related to optometry. Rights to three products from Sirion Therapeutics Inc. will be secured by Alcon Inc. Sight Savers International is in its 60th year of working to help save people in developing countries from blindness. Almost 500,000 U.S. dollars was raised from the World Sight Day Challenge 2009 event for vision care programs for people without access to basic eye care services.

The article offers the author's insights on the use of smart contact lenses in eye care. Topics include the release of Triggerfish contact lenses which monitors eye movements, the launch of a platform called CareKit which aims to further integrate technology and health by allowing developers write software so that patients can record symptoms and effects of medication in real time, and the continues work of medical company Alcon and American technology company Google Inc. on the subject.

The article discusses issues and topics related to Pataday solution, a topical ocular allergy drug from Alcon. According to some clinical experts, there is a growing body of evidence from clinical trials that demonstrate the proven relief after using the solution. The favorable clinical results were attributed to the higher concentration of olopatadine in the drug which increases the duration of effect and no problems with comfort or other ocular complications.

The article offers information on the "Give it a Go" campaign that promotes contact lenses from medical company Alcon. Topics discussed include the views of trade marketing executive Jennifer Devine regarding the advantage of the campaign for encouraging customers to wear contact lenses, the effort of the company to provide point of sale materials regarding the benefits of contact lenses, and the benefits of the campaign for eye care practitioners.

The article reports on a research by Alcon, a global medical firm specializing in eye care products, which suggests that the optical practice and eye care practitioners are missing out on dry eye market.